QUOIN PHARMACEUTICALS LT-ADR (QNRX) Stock Analyst Earnings Estimates
NASDAQ:QNRX - Nasdaq - US74907L3006 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 454.38% | N/A -23.59% | N/A 59.08% | N/A 28.14% | N/A 17.02% | |||||||
| EBITDA YoY % growth | N/A | N/A | -8.01M | -6.04M 24.59% | -3.86M 36.09% | -5.96M -54.40% | -9.16M -53.69% | -9.275M -1.25% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A | N/A -57.89% | -8.14M -17.46% | -6.27M 22.97% | -4.07M 35.09% | -6.06M -48.89% | -9.26M -52.81% | -9.379M -1.28% | N/A -4.08% | N/A -7.03% | N/A 52.32% | N/A 417.36% | N/A 138.25% | N/A 81.85% | N/A 33.95% | N/A 19.52% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A -64.36% | N/A | N/A | N/A | N/A | -85.08 88.57% | -10.24 87.96% | N/A 79.28% | N/A 33.17% | N/A 96.40% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.47 77.44% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -2.496M -12.53% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.47 75.90% | -0.50 | 0.03 | 6.60% |
| Q2 2024 Q2Q % growth | -0.39 81.69% | -0.62 | 0.23 | 37.32% |
| Q1 2024 Q2Q % growth | -1.11 72.79% | -0.78 | -0.33 | -43.19% |
| Q4 2023 Q2Q % growth | -2.08 57.72% | -2.36 | 0.28 | 11.91% |
| Q3 2023 Q2Q % growth | -1.95 82.71% | -2.78 | 0.83 | 29.77% |
| Q2 2023 Q2Q % growth | -2.13 94.52% | -2.88 | 0.75 | 25.95% |
| Q1 2023 Q2Q % growth | -4.08 86.40% | -3.46 | -0.62 | -17.92% |
| Q4 2022 Q2Q % growth | -4.92 45.26% | -7.56 | 2.64 | 34.96% |
| Q3 2022 Q2Q % growth | -11.28 -240.27% | -16.50 | 5.22 | 31.63% |
| Q2 2022 Q2Q % growth | -38.88 | -37.74 | -1.14 | -3.02% |
| Q1 2022 Q2Q % growth | -30.00 | -40.55 | 10.55 | 26.01% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | 7.28% |
| Revenue | N/A | N/A | N/A | N/A |